Share this to:

Support & Insight for the Autumn of Life

WSJ: Rember Tackles the Tau behind Alzheimer’s

VIDEO

Watch this Wall Street Journal interview on why Dr. Wischik sees tau as a more worthwhile anti-Alzheimer’s target than plaque. Learn more about TauRx’ Alzheimer’s trial drug called Rember.

WSJ’s Shirley Wang spoke with Dr. Wischik about his work on this new drug to treat the devastating disease.



Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
B. Berger

B. Berger

Visit Our Pages On:

Welcome

This site was inspired by my Mom’s autoimmune dementia.

It is a place where we separate out the wheat from the chaffe, the important articles & videos from each week’s river of news. With a new post on Alzheimer’s or dementia appearing on the internet every 7 minutes, the site’s focus on the best information has been a help to many over the past 15 years. Thanks to our many subscribers for your supportive feedback.

The site is dedicated to all those preserving the dignity of the community of people living with dementia.

Peter Berger, Editor

Related

black framed eyeglasses on blue bedsheet
Suvorexant Reduces Alzheimer's Tau & Amyloid Beta
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. Th...
130922-vidgam.jpeg
Memories Sharpen in Video Game Study
Scientists at UC San Francisco have found a way to reverse some of the negative effects of aging on the brain, using ...
Older%2Bwoman%2Bby%2BSilviarita%2Bat%2BPixabay.jpeg
Why Do 'Superagers' Learn Like 25-Year-Olds?
What kind of brain enables "superagers" to learn and recall novel information as well as a 25-year-old? Researchers h...

Books

Amazon Books
0
Would love your thoughts, please comment.x
()
x
News to Get at the Truth

Subscribe To Our Weekly Newsletter

Enjoy thought-provoking videos & articles
News to Get at the Truth

Subscribe To Our Weekly Newsletter